SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-17-335917
Filing Date
2017-11-07
Accepted
2017-11-07 17:18:31
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3/A d490240ds3a.htm S-3/A 658765
2 EX-5.1 d490240dex51.htm EX-5.1 29368
3 EX-23.1 d490240dex231.htm EX-23.1 1726
4 GRAPHIC g490240g1107024720783.jpg GRAPHIC 1450
5 GRAPHIC g490240g1107024721079.jpg GRAPHIC 1946
6 GRAPHIC g490240g1107024721188.jpg GRAPHIC 3076
7 GRAPHIC g490240g1107024721391.jpg GRAPHIC 2793
8 GRAPHIC g490240g1107024904213.jpg GRAPHIC 2524
  Complete submission text file 0001193125-17-335917.txt   708049
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-218607 | Film No.: 171184408
SIC: 2834 Pharmaceutical Preparations